Search

Author/Creator Brands, Michael

3. Discovery and SAR of Novel 2, 3‐Dihydroimidazo[1, 2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946). (16th June 2016)

Authors:
Scott, William J.; Hentemann, Martin F.; Rowley, R. Bruce; Bull, Cathy O.; Jenkins, Susan; Bullion, Ann M.; Johnson, Jeffrey; Redman, Anikó; Robbins, Arthur H.; Esler, William; Fracasso, R. Paul; Garrison, Timothy; Hamilton, Mark; Michels, Martin; Wood, Jill E.; Wilkie, Dean P.; Xiao, Hong; Levy,...
Journal:
ChemMedChem
Issue:
Volume 11:Number 14(2016)
Page Start:
1517
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. (16th October 2017)

Authors:
Lücking, Ulrich; Scholz, Arne; Lienau, Philip; Siemeister, Gerhard; Kosemund, Dirk; Bohlmann, Rolf; Briem, Hans; Terebesi, Ildiko; Meyer, Kirstin; Prelle, Katja; Denner, Karsten; Bömer, Ulf; Schäfer, Martina; Eis, Knut; Valencia, Ray; Ince, Stuart; von Nussbaum, Franz; Mumberg, Dominik; Ziegelbau...
Journal:
ChemMedChem
Issue:
Volume 12:Number 21(2017)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗